Loading clinical trials...

Neuroinflammation in FTLD | Clinical Trials | Clareo Health

Active Not RecruitingNCT06870838

Neuroinflammation in FTLD

The goal of this observational study is to investigate the role of neuroinflammation in frontotemporal lobar degeneration (FTLD). The main aims of this study are: 1. To elucidate the role and timing ...

Lead sponsor: Leiden University Medical Center•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Speech and Language Interventions for Italian People With PPA

NCT06739967 · Primary Progressive Aphasia(PPA)

RECRUITING

UPenn Observational Research Repository on Neurodegenerative Disease

NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more

RECRUITINGNA

Long Term Effect of Brain Stimulation in PPA

NCT07158216 · Primary Progressive Aphasia(PPA)

Enrolling By InvitationNA

Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely

NCT06597071 · Parkinson Disease, Progressive Supranuclear Palsy(PSP), and more

Not Yet RecruitingNA

Targeted Transcranial Magnetic Stimulation to Improve Language and Speech in Patients With Primary Progressive Aphasia

NCT06921265 · Primary Progressive Aphasia(PPA)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 11, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment110

Start dateJul 2023

Last updatedSep 11, 2025

Condition

Corticobasal Syndrome(CBS)Primary Progressive Aphasia(PPA)Progressive Supranuclear Palsy(PSP)Behavioral Variant Frontotemporal Dementia (bvFTD)Frontotemporal Lobar Degeneration (FTLD)

Locations shown

Leiden University Medical Center

Leiden

Erasmus MC

Rotterdam

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 11, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions